Peregrine Capital Management LLC Purchases 2,168 Shares of Prestige Consumer Healthcare Inc (NYSE:PBH)

Peregrine Capital Management LLC boosted its position in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 1.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 151,513 shares of the company’s stock after purchasing an additional 2,168 shares during the period. Peregrine Capital Management LLC owned about 0.30% of Prestige Consumer Healthcare worth $5,691,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Huntington National Bank increased its holdings in Prestige Consumer Healthcare by 45.4% during the 1st quarter. Huntington National Bank now owns 782 shares of the company’s stock worth $29,000 after purchasing an additional 244 shares in the last quarter. Advisor Group Holdings Inc. acquired a new stake in Prestige Consumer Healthcare in the 1st quarter valued at about $62,000. Contravisory Investment Management Inc. acquired a new stake in Prestige Consumer Healthcare in the 2nd quarter valued at about $156,000. Aigen Investment Management LP acquired a new stake in Prestige Consumer Healthcare during the first quarter worth approximately $165,000. Finally, Highlander Capital Management LLC acquired a new stake in Prestige Consumer Healthcare during the first quarter worth approximately $183,000.

Several equities research analysts have issued reports on the stock. Zacks Investment Research downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating and set a $42.00 price objective for the company. in a research report on Thursday, May 14th. BMO Capital Markets raised their price objective on shares of Prestige Consumer Healthcare from $91.00 to $95.00 and gave the stock a “market perform” rating in a research report on Friday, July 24th. DA Davidson raised their price objective on shares of Prestige Consumer Healthcare from $43.00 to $47.00 in a research report on Wednesday, April 15th. Sidoti upgraded shares of Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $46.00 price objective for the company in a research report on Monday, June 29th. Finally, ValuEngine downgraded shares of Prestige Consumer Healthcare from a “sell” rating to a “strong sell” rating in a research report on Thursday, July 2nd. One analyst has rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $65.43.

NYSE PBH opened at $37.19 on Friday. The company has a current ratio of 2.44, a quick ratio of 1.67 and a debt-to-equity ratio of 1.50. Prestige Consumer Healthcare Inc has a 1-year low of $27.40 and a 1-year high of $46.12. The company has a 50 day moving average of $38.20 and a 200-day moving average of $39.22. The company has a market cap of $1.87 billion, a price-to-earnings ratio of 13.38, a PEG ratio of 3.11 and a beta of 0.80.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.82 earnings per share for the quarter, beating analysts’ consensus estimates of $0.74 by $0.08. Prestige Consumer Healthcare had a net margin of 14.77% and a return on equity of 13.33%. The company had revenue of $251.20 million during the quarter, compared to the consensus estimate of $239.65 million. During the same period in the previous year, the business earned $0.72 earnings per share. The firm’s quarterly revenue was up 4.2% on a year-over-year basis. On average, equities research analysts forecast that Prestige Consumer Healthcare Inc will post 2.99 earnings per share for the current year.

In related news, CEO Ronald M. Lombardi sold 29,593 shares of Prestige Consumer Healthcare stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $40.00, for a total value of $1,183,720.00. Following the transaction, the chief executive officer now directly owns 154,630 shares of the company’s stock, valued at $6,185,200. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.20% of the company’s stock.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Read More: What Does Beta Mean In Stock Selection?

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.